Per Olav Vandvik

28.3k total citations · 7 hit papers
179 papers, 11.9k citations indexed

About

Per Olav Vandvik is a scholar working on Public Health, Environmental and Occupational Health, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Per Olav Vandvik has authored 179 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Public Health, Environmental and Occupational Health, 45 papers in General Health Professions and 34 papers in Economics and Econometrics. Recurrent topics in Per Olav Vandvik's work include Clinical practice guidelines implementation (43 papers), Health Systems, Economic Evaluations, Quality of Life (33 papers) and Meta-analysis and systematic reviews (25 papers). Per Olav Vandvik is often cited by papers focused on Clinical practice guidelines implementation (43 papers), Health Systems, Economic Evaluations, Quality of Life (33 papers) and Meta-analysis and systematic reviews (25 papers). Per Olav Vandvik collaborates with scholars based in Norway, Canada and United States. Per Olav Vandvik's co-authors include Gordon Guyatt, Elie A. Akl, David L. Veenstra, Per G. Farup, Thomas Agoritsas, Pablo Alonso‐Coello, Reed Siemieniuk, Ian A. Greer, Anne-Marie Prabulos and Shannon M. Bates and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Internal Medicine.

In The Last Decade

Per Olav Vandvik

171 papers receiving 11.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy

2012 909 citations Per Olav Vandvik et al. profile →
Evidence-Based Management of Anticoagulant Therapy

2012 887 citations Per Olav Vandvik, Gordon Guyatt et al. profile →
Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients

2015 597 citations Per Olav Vandvik, Gordon Guyatt et al. BMJ profile →
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children

2013 572 citations Per Olav Vandvik, Gordon Guyatt et al. profile →
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines

2016 495 citations Pablo Alonso‐Coello, Andrew D Oxman et al. BMJ profile →
Guideline for opioid therapy and chronic noncancer pain

2017 473 citations Jason W. Busse, Rachel Couban et al. profile →
GRADE Guidelines 28: Use of GRADE for the assessment of evidence about prognostic factors: rating certainty in identification of groups of patients with different absolute risks

2020 252 citations Farid Foroutan, Gordon Guyatt et al. Journal of Clinical Epidemiology profile →

Peers

Countries citing papers authored by Per Olav Vandvik

Since Specialization

Citations

This map shows the geographic impact of Per Olav Vandvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Olav Vandvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Olav Vandvik more than expected).

Fields of papers citing papers by Per Olav Vandvik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Olav Vandvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Olav Vandvik. The network helps show where Per Olav Vandvik may publish in the future.

Co-authorship network of co-authors of Per Olav Vandvik

This figure shows the co-authorship network connecting the top 25 collaborators of Per Olav Vandvik. A scholar is included among the top collaborators of Per Olav Vandvik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Olav Vandvik. Per Olav Vandvik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Benefits, burden, and harms of computer aided polyp detection with artificial intelligence in colorectal cancer screening: microsimulation modelling study 2025 ·PubMed ·(unknown), Cesare Hassan, Loredana Correale, Nastazja Pilonis, Lise Mørkved Helsingen, Marco Spadaccini, Alessandro Repici, Farid Foroutan, Per Olav Vandvik, Shahnaz Sultan, Magnus Løberg, Mette Kalager, Yuichi Mori, Michael Bretthauer	2
2	Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis 2024 ·SHILAP Revista de lepidopterología ·Dena Zeraatkar, Tyler Pitre, (unknown), (unknown), King‐Hwa Ling, (unknown), Rachel Couban, Letícia Kawano-Dourado, Eirik Klami Kristianslund, Per Olav Vandvik	0
3	A systematic survey of 200 systematic reviews with network meta-analysis (published 2020–2021) reveals that few reviews report structured evidence summaries 2024 ·Journal of Clinical Epidemiology ·(unknown), Xiaoqin Wang, Tyler Pitre, (unknown), Areti Angeliki Veroniki, Carole Lunny, Andrea C. Tricco, Thomas Agoritsas, Per Olav Vandvik	3
4	Interpretation and use of a decision support tool for multiple treatment options: a combined randomised controlled trial and survey of medical students 2023 ·BMJ evidence-based medicine ·(unknown), (unknown), Ashley Elizabeth Muller, Per Olav Vandvik	3
5	A novel framework for incorporating patient values and preferences in making guideline recommendations: guideline panel surveys 2023 ·Journal of Clinical Epidemiology ·Linan Zeng, Lise Mørkved Helsingen, Michael Bretthauer, Thomas Agoritsas, Per Olav Vandvik, Reem A. Mustafa, Jason W. Busse, Reed Siemieniuk, Lyubov Lytvyn, Shelly‐Anne Li, Mengting Yang, (unknown), Lingli Zhang, Romina Brignardello‐Petersen, Gordon H. Guyatt	10
6	Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline 2023 ·BMJ ·Jason W. Busse, (unknown), Alonso Carrasco‐Labra, Justin Durham, David Mock, Joanna M. Zakrzewska, Carolyn F. Palmer, Caroline Samer, Matteo Coen, (unknown), Thomas Hoppe, Gordon Guyatt, Holly N. Crandon, Liang Yao, Behnam Sadeghirad, Per Olav Vandvik, Reed Siemieniuk, (unknown), (unknown), Thomas Agoritsas	51
7	Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis 2022 ·SHILAP Revista de lepidopterología ·Dena Zeraatkar, Ellen Cusano, Juan Pablo Díaz Martinez, Anila Qasim, (unknown), Elena Kum, Jessica Bartoszko, Tahira Devji, Thomas Agoritsas, Gordon Guyatt, Ariel Izcovich, Assem M. Khamis, François Lamontagne, Bram Rochwerg, Per Olav Vandvik, Romina Brignardello‐Petersen, Reed Siemieniuk	14
8	Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials 2022 ·BMJ Open ·Ariel Izcovich, Reed Siemieniuk, Jessica Bartoszko, Long Ge, Dena Zeraatkar, Elena Kum, Anila Qasim, Assem M. Khamis, Bram Rochwerg, Thomas Agoritsas, Derek K. Chu, Shelley McLeod, Reem A. Mustafa, Per Olav Vandvik, Romina Brignardello‐Petersen	35
9	PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis 2022 ·BMJ ·Safi U. Khan, Siva H. Yedlapati, Ahmad Naeem Lone, Qiukui Hao, Gordon Guyatt, Nicolas Delvaux, Geertruida E Bekkering, Per Olav Vandvik, Irbaz Bin Riaz, Sheyu Li, Bert Aertgeerts, Nicolas Rodondi	65
10	Establishing thresholds for important benefits considering the harms of screening interventions 2020 ·BMJ Open ·Lise Mørkved Helsingen, Linan Zeng, Reed Siemieniuk, Lyubov Lytvyn, Per Olav Vandvik, Thomas Agoritsas, Michael Bretthauer, Gordon Guyatt	4
11	Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis 2019 ·BMJ Open ·Henriette C. Jodal, Lise Mørkved Helsingen, Joseph C. Anderson, Lyubov Lytvyn, Per Olav Vandvik, Louise Emilsson	85
12	Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence 2018 ·BMJ Open ·Hassan Mir, Reed Siemieniuk, Long Ge, Farid Foroutan, Michael Fralick, (unknown), Luciane Cruz Lopes, Ton Kuijpers, Jean‐Louis Mas, Per Olav Vandvik, Thomas Agoritsas, Gordon Guyatt	42
13	Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline 2018 ·BMJ ·Kameshwar Prasad, Reed Siemieniuk, Qiukui Hao, Gordon Guyatt, Martin O’Donnell, Lyubov Lytvyn, Anja Fog Heen, Thomas Agoritsas, Per Olav Vandvik, Sankar Prasad Gorthi, (unknown), (unknown), Jennifer Muller, Brenda M. Booth, (unknown), (unknown), (unknown), (unknown), (unknown), Bram Rochwerg	55
14	Multilayered and digitally structured presentation formats of trustworthy recommendations: a combined survey and randomised trial 2017 ·BMJ Open ·Linn Brandt, Per Olav Vandvik, Pablo Alonso‐Coello, Elie A. Akl, Judith Thornton, David Rigau, Katie Adams, Paul O’Connor, Gordon Guyatt, Annette Kristiansen	14
15	Application of minimal important differences in degenerative knee disease outcomes: a systematic review and case study to inform BMJ Rapid Recommendations 2017 ·BMJ Open ·Tahira Devji, Gordon Guyatt, Lyubov Lytvyn, Romina Brignardello‐Petersen, Farid Foroutan, Behnam Sadeghirad, Rachelle Buchbinder, Rudolf W. Poolman, Ian A. Harris, Alonso Carrasco‐Labra, Reed Siemieniuk, Per Olav Vandvik	87
16	Values and preferences of women living with HIV who are pregnant, postpartum or considering pregnancy on choice of antiretroviral therapy during pregnancy 2017 ·BMJ Open ·Lyubov Lytvyn, Reed Siemieniuk, (unknown), Allyson Ion, Yaping Chang, Małgorzata M Bała, Veena Manja, Reza Mirza, René Rodríguez‐Gutiérrez, Hassan Mir, Laura Banfield, Per Olav Vandvik, Susan Bewley	16
17	Meta-analysis of antibiotics versus appendicectomy for non-perforated acute appendicitis 2016 ·British journal of surgery ·Ville Sallinen, Elie A. Akl, John J. You, Arnav Agarwal, Sami Shoucair, Per Olav Vandvik, Thomas Agoritsas, Diane Heels‐Ansdell, Gordon Guyatt, Kari A.O. Tikkinen	172
18	Reporting missing participant data in randomised trials: systematic survey of the methodological literature and a proposed guide 2015 ·BMJ Open ·Elie A. Akl, Khaled Shawwa, Lara A Kahale, Thomas Agoritsas, Romina Brignardello‐Petersen, Jason W. Busse, Alonso Carrasco‐Labra, Shanil Ebrahim, Bradley C. Johnston, Ignacio Neumann, Iván Solà, Xin Sun, Per Olav Vandvik, Yuqing Zhang, Pablo Alonso‐Coello, Gordon Guyatt	33
19	SUPPORT Tools for evidence-informed health Policymaking (STP) 2: Improving how your organisation supports the use of research evidence to inform policymaking 2009 ·Health Research Policy and Systems ·Andrew D Oxman, Per Olav Vandvik, John N. Lavis, Atle Fretheim, Simon Lewin	46
20	Kunnskapsgrunnlaget for behandlingslinjer – en foreløpig oversikt. 2007 ·Duo Research Archive (University of Oslo) ·Signe Flottorp, (unknown), Per Olav Vandvik, Marit Johansen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact